Product Code: A11130
The global dermocosmetics market is envisioned to garner $13, 0460.6 million by 2030, growing from $51,100 million in 2021 at a CAGR of 11.1% from 2022 to 2030.
Cosmetics and dermatology are two medical streams that are combined together to form dermocosmetics. All cosmetics products that may be applied to the skin or hair and that address particular skin issues such as dry skin, oily skin, skin ailments including acne, pimples, blemishes, marks, and others are referred to as dermacosmetics. Need of cosmetics in skin care is majorly due to rising awareness regarding its effectiveness and technological advancements in the industry are expected to have a significant impact on demand for dermacosmetics in the years to come.
Consumers are becoming more self-conscious about their appearance as it enhances their personality. In order to lessen the effects of aging, wrinkles, acne, and fine lines, they are increasingly preferring to spend more money on protecting and whitening their skin by using various dermocosmetic products. Furthermore, the trend towards shopping on e-commerce websites is projected to be essential for the performance of the skincare dermacosmetics market throughout the forecast period, due to customers' busy lifestyles and adopting most convenient ways to buy through online channel. Cosmetic products contain chemical compounds which can have a variety of negative effects on skin. Manufacturing businesses have used cutting-edge techniques to boost sales of their cosmetics items, such as introduction of new products with all-natural ingredients and attractive packaging. In the forecast, these factors are projected to accelerate the market revenue growth.
The majority of industries were shut down as a result of the COVID-19 pandemic. Import and export interruption, supply chain issues, and shutting down of several manufacturing facilities resulted in delaying the manufacturing of new products. Due to dermocosmetics' effectiveness in maintaining a healthy skincare routine during the pandemic, dermocosmetics witnessed a little boost in demand. Due to the lockdown in several countries, people were unable to continue their therapy appointments. As a result, they were able to continue practicing skincare using dermacosmetics at home itself.
Additionally, dermotologists started conducting online consultations, due to the restriction and guidelines provided by various governments. However, during the pandemic, high product costs and a change in consumer tastes restricted the market growth.
The key players profiled in the dermocosmetics market report include Johnson & Johnson, Bausch Health Companies Inc., Galderma, Procter & Gamble, AbbVie, L'Oreal, Beiersdorf, Kanebo Cosmetics Inc., Estee Lauder Companies, Shiseido Company, and ZO Skin Health Inc.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the dermocosmetics market analysis from 2021 to 2030 to identify the prevailing dermocosmetics market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the dermocosmetics market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global dermocosmetics market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
By Treatment
By Distribution Channel
- Pharmacy and Retail Stores
- Online
By End-user
- Clinics, Medical Spas, and Salons
- Hospitals
- At-Home
By Region
- North America
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of Latin America
- Key Market Players
- johnson & johnson, inc.
- Bausch Health Companies Inc.
- galderma
- Procter & Gamble
- Allergan plc
- L'Oreal S.A
- beiersdorf
- Kanebo Cosmetics Inc.
- Estee Lauder Companies Inc.
- Shiseido Company
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter's five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- 3.7.Value Chain Analysis
- 3.8.Market Share Analysis
- 3.9.Regulatory Guidelines
- 3.10.Key Regulation Analysis
- 3.11.Patent Landscape
CHAPTER 4: DERMOCOSMETICS MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Skin Care
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Hair Care
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
CHAPTER 5: DERMOCOSMETICS MARKET, BY TREATMENT
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Skin
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Hair
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
CHAPTER 6: DERMOCOSMETICS MARKET, BY DISTRIBUTION CHANNEL
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Pharmacy and Retail Stores
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Online
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
CHAPTER 7: DERMOCOSMETICS MARKET, BY END-USER
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 Clinics, Medical Spas, and Salons
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
- 7.3 Hospitals
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
- 7.4 At-Home
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country
CHAPTER 8: DERMOCOSMETICS MARKET, BY REGION
- 8.1 Overview
- 8.1.1 Market size and forecast
- 8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Product
- 8.2.3 North America Market size and forecast, by Treatment
- 8.2.4 North America Market size and forecast, by Distribution Channel
- 8.2.5 North America Market size and forecast, by End-user
- 8.2.6 North America Market size and forecast, by country
- 8.2.6.1 U.S.
- 8.2.6.1.1 Market size and forecast, by Product
- 8.2.6.1.2 Market size and forecast, by Treatment
- 8.2.6.1.3 Market size and forecast, by Distribution Channel
- 8.2.6.1.4 Market size and forecast, by End-user
- 8.2.6.2 Canada
- 8.2.6.2.1 Market size and forecast, by Product
- 8.2.6.2.2 Market size and forecast, by Treatment
- 8.2.6.2.3 Market size and forecast, by Distribution Channel
- 8.2.6.2.4 Market size and forecast, by End-user
- 8.2.6.3 Mexico
- 8.2.6.3.1 Market size and forecast, by Product
- 8.2.6.3.2 Market size and forecast, by Treatment
- 8.2.6.3.3 Market size and forecast, by Distribution Channel
- 8.2.6.3.4 Market size and forecast, by End-user
- 8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Product
- 8.3.3 Europe Market size and forecast, by Treatment
- 8.3.4 Europe Market size and forecast, by Distribution Channel
- 8.3.5 Europe Market size and forecast, by End-user
- 8.3.6 Europe Market size and forecast, by country
- 8.3.6.1 Germany
- 8.3.6.1.1 Market size and forecast, by Product
- 8.3.6.1.2 Market size and forecast, by Treatment
- 8.3.6.1.3 Market size and forecast, by Distribution Channel
- 8.3.6.1.4 Market size and forecast, by End-user
- 8.3.6.2 France
- 8.3.6.2.1 Market size and forecast, by Product
- 8.3.6.2.2 Market size and forecast, by Treatment
- 8.3.6.2.3 Market size and forecast, by Distribution Channel
- 8.3.6.2.4 Market size and forecast, by End-user
- 8.3.6.3 Italy
- 8.3.6.3.1 Market size and forecast, by Product
- 8.3.6.3.2 Market size and forecast, by Treatment
- 8.3.6.3.3 Market size and forecast, by Distribution Channel
- 8.3.6.3.4 Market size and forecast, by End-user
- 8.3.6.4 Spain
- 8.3.6.4.1 Market size and forecast, by Product
- 8.3.6.4.2 Market size and forecast, by Treatment
- 8.3.6.4.3 Market size and forecast, by Distribution Channel
- 8.3.6.4.4 Market size and forecast, by End-user
- 8.3.6.5 United Kingdom
- 8.3.6.5.1 Market size and forecast, by Product
- 8.3.6.5.2 Market size and forecast, by Treatment
- 8.3.6.5.3 Market size and forecast, by Distribution Channel
- 8.3.6.5.4 Market size and forecast, by End-user
- 8.3.6.6 Rest of Europe
- 8.3.6.6.1 Market size and forecast, by Product
- 8.3.6.6.2 Market size and forecast, by Treatment
- 8.3.6.6.3 Market size and forecast, by Distribution Channel
- 8.3.6.6.4 Market size and forecast, by End-user
- 8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Product
- 8.4.3 Asia-Pacific Market size and forecast, by Treatment
- 8.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
- 8.4.5 Asia-Pacific Market size and forecast, by End-user
- 8.4.6 Asia-Pacific Market size and forecast, by country
- 8.4.6.1 China
- 8.4.6.1.1 Market size and forecast, by Product
- 8.4.6.1.2 Market size and forecast, by Treatment
- 8.4.6.1.3 Market size and forecast, by Distribution Channel
- 8.4.6.1.4 Market size and forecast, by End-user
- 8.4.6.2 Japan
- 8.4.6.2.1 Market size and forecast, by Product
- 8.4.6.2.2 Market size and forecast, by Treatment
- 8.4.6.2.3 Market size and forecast, by Distribution Channel
- 8.4.6.2.4 Market size and forecast, by End-user
- 8.4.6.3 India
- 8.4.6.3.1 Market size and forecast, by Product
- 8.4.6.3.2 Market size and forecast, by Treatment
- 8.4.6.3.3 Market size and forecast, by Distribution Channel
- 8.4.6.3.4 Market size and forecast, by End-user
- 8.4.6.4 South Korea
- 8.4.6.4.1 Market size and forecast, by Product
- 8.4.6.4.2 Market size and forecast, by Treatment
- 8.4.6.4.3 Market size and forecast, by Distribution Channel
- 8.4.6.4.4 Market size and forecast, by End-user
- 8.4.6.5 Australia
- 8.4.6.5.1 Market size and forecast, by Product
- 8.4.6.5.2 Market size and forecast, by Treatment
- 8.4.6.5.3 Market size and forecast, by Distribution Channel
- 8.4.6.5.4 Market size and forecast, by End-user
- 8.4.6.6 Rest of Asia-Pacific
- 8.4.6.6.1 Market size and forecast, by Product
- 8.4.6.6.2 Market size and forecast, by Treatment
- 8.4.6.6.3 Market size and forecast, by Distribution Channel
- 8.4.6.6.4 Market size and forecast, by End-user
- 8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Product
- 8.5.3 LAMEA Market size and forecast, by Treatment
- 8.5.4 LAMEA Market size and forecast, by Distribution Channel
- 8.5.5 LAMEA Market size and forecast, by End-user
- 8.5.6 LAMEA Market size and forecast, by country
- 8.5.6.1 Brazil
- 8.5.6.1.1 Market size and forecast, by Product
- 8.5.6.1.2 Market size and forecast, by Treatment
- 8.5.6.1.3 Market size and forecast, by Distribution Channel
- 8.5.6.1.4 Market size and forecast, by End-user
- 8.5.6.2 Saudi Arabia
- 8.5.6.2.1 Market size and forecast, by Product
- 8.5.6.2.2 Market size and forecast, by Treatment
- 8.5.6.2.3 Market size and forecast, by Distribution Channel
- 8.5.6.2.4 Market size and forecast, by End-user
- 8.5.6.3 United Arab Emirates
- 8.5.6.3.1 Market size and forecast, by Product
- 8.5.6.3.2 Market size and forecast, by Treatment
- 8.5.6.3.3 Market size and forecast, by Distribution Channel
- 8.5.6.3.4 Market size and forecast, by End-user
- 8.5.6.4 South Africa
- 8.5.6.4.1 Market size and forecast, by Product
- 8.5.6.4.2 Market size and forecast, by Treatment
- 8.5.6.4.3 Market size and forecast, by Distribution Channel
- 8.5.6.4.4 Market size and forecast, by End-user
- 8.5.6.5 Rest of Latin America
- 8.5.6.5.1 Market size and forecast, by Product
- 8.5.6.5.2 Market size and forecast, by Treatment
- 8.5.6.5.3 Market size and forecast, by Distribution Channel
- 8.5.6.5.4 Market size and forecast, by End-user
CHAPTER 9: COMPANY LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product Mapping of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Key developments
CHAPTER 10: COMPANY PROFILES
- 10.1 johnson & johnson, inc.
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
- 10.2 Bausch Health Companies Inc.
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
- 10.3 galderma
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
- 10.4 Procter & Gamble
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
- 10.5 Allergan plc
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
- 10.6 L'Oreal S.A
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
- 10.7 beiersdorf
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
- 10.8 Kanebo Cosmetics Inc.
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
- 10.9 Estee Lauder Companies Inc.
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
- 10.10 Shiseido Company
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments